PROCEPT BioRobotics Corporation PRCT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -114.86M | -109.76M | -102.47M | -95.57M | -84.58M |
| Total Depreciation and Amortization | 7.97M | 7.05M | 6.65M | 6.39M | 6.13M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 53.59M | 54.01M | 51.10M | 48.04M | 48.22M |
| Change in Net Operating Assets | -23.39M | -25.64M | -25.41M | -7.84M | -40.82M |
| Cash from Operations | -76.69M | -74.34M | -70.13M | -48.99M | -71.05M |
| Capital Expenditure | -8.38M | -10.59M | -10.43M | -9.36M | -8.68M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.38M | -10.59M | -10.43M | -9.36M | -8.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.26M | 10.24M | 10.12M | 11.19M | 177.28M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.26M | 10.24M | 10.12M | 11.19M | 177.28M |
| Foreign Exchange rate Adjustments | -95.00K | -113.00K | -116.00K | -74.00K | -33.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -75.91M | -74.80M | -70.57M | -47.22M | 97.52M |